Market Overview
According to DIResearch's in-depth investigation and research, the global CGT CDMO market size will reach 7,534.87 Million USD in 2025 and is projected to reach 33,621.06 Million USD by 2032, with a CAGR of 23.82% (2025-2032). Notably, the China CGT CDMO market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A CGT CDMO (Contract Development and Manufacturing Organization for Cell and Gene Therapy) is a specialized service provider that supports the biopharmaceutical industry by offering comprehensive development and manufacturing solutions for cell and gene therapies. These organizations facilitate every stage of the therapy development process, from research and development to clinical trial material production, regulatory compliance, and large-scale commercial manufacturing. By leveraging advanced facilities, expert personnel, and regulatory expertise, CGT CDMOs enable biotech and pharmaceutical companies to accelerate the development and commercialization of innovative treatments. This allows companies to focus on their core competencies while ensuring efficient, high-quality production and adherence to regulatory standards, ultimately speeding up the delivery of advanced therapies to patients.
The major global suppliers of CGT CDMO include WuXi AppTec, OBiO, GenScript, Porton, Lonza, Pharmaron, Catalent, Thermo Fisher, Oxford Biomedica (OXB), Asymchem, Rentschler Biopharma, Novartis, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of CGT CDMO. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global CGT CDMO market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the CGT CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CGT CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of CGT CDMO Include:
WuXi AppTec
OBiO
GenScript
Porton
Lonza
Pharmaron
Catalent
Thermo Fisher
Oxford Biomedica (OXB)
Asymchem
Rentschler Biopharma
Novartis
CGT CDMO Product Segment Include:
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA
CGT CDMO Product Application Include:
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global CGT CDMO Industry PESTEL Analysis
Chapter 3: Global CGT CDMO Industry Porter's Five Forces Analysis
Chapter 4: Global CGT CDMO Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global CGT CDMO Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global CGT CDMO Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, CGT CDMO Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
- 1 CGT CDMO Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 CGT CDMO Product by Type
- 1.2.1 Immune Cells
- 1.2.2 Stem Cells
- 1.2.3 Viral Vectors
- 1.2.4 Plasmid DNA
- 1.3 CGT CDMO Product by Application
- 1.3.1 Pharmaceutical and Biotechnology Companies
- 1.3.2 Research and Academic Institutions
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global CGT CDMO Market Size Analysis (2020-2032)
- 1.5 CGT CDMO Market Development Status and Trends
- 1.5.1 CGT CDMO Industry Development Status Analysis
- 1.5.2 CGT CDMO Industry Development Trends Analysis
- 2 CGT CDMO Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 CGT CDMO Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global CGT CDMO Market Analysis by Country
- 4.1 Global CGT CDMO Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global CGT CDMO Revenue Analysis by Country (2020-2025)
- 4.1.2 Global CGT CDMO Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.5 China CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.6 France CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.14 India CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa CGT CDMO Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global CGT CDMO Market Revenue by Key Suppliers (2021-2025)
- 5.2 CGT CDMO Competitive Landscape Analysis and Market Dynamic
- 5.2.1 CGT CDMO Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 CGT CDMO Market Analysis by Type
- 6.1 Global CGT CDMO Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global CGT CDMO Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 WuXi AppTec
- 7.1.1 WuXi AppTec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 WuXi AppTec CGT CDMO Product Portfolio
- 7.1.3 WuXi AppTec CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 OBiO
- 7.2.1 OBiO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 OBiO CGT CDMO Product Portfolio
- 7.2.3 OBiO CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 GenScript
- 7.3.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GenScript CGT CDMO Product Portfolio
- 7.3.3 GenScript CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Porton
- 7.4.1 Porton Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Porton CGT CDMO Product Portfolio
- 7.4.3 Porton CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Lonza
- 7.5.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Lonza CGT CDMO Product Portfolio
- 7.5.3 Lonza CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Pharmaron
- 7.6.1 Pharmaron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Pharmaron CGT CDMO Product Portfolio
- 7.6.3 Pharmaron CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Catalent
- 7.7.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Catalent CGT CDMO Product Portfolio
- 7.7.3 Catalent CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Thermo Fisher
- 7.8.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Thermo Fisher CGT CDMO Product Portfolio
- 7.8.3 Thermo Fisher CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Oxford Biomedica (OXB)
- 7.9.1 Oxford Biomedica (OXB) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Oxford Biomedica (OXB) CGT CDMO Product Portfolio
- 7.9.3 Oxford Biomedica (OXB) CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Asymchem
- 7.10.1 Asymchem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Asymchem CGT CDMO Product Portfolio
- 7.10.3 Asymchem CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Rentschler Biopharma
- 7.11.1 Rentschler Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Rentschler Biopharma CGT CDMO Product Portfolio
- 7.11.3 Rentschler Biopharma CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Novartis
- 7.12.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Novartis CGT CDMO Product Portfolio
- 7.12.3 Novartis CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 CGT CDMO Industry Chain Analysis
- 8.2 CGT CDMO Product Downstream Application Analysis
- 8.2.1 Global CGT CDMO Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global CGT CDMO Revenue and Forecast by Application (2020-2032)
- 8.3 CGT CDMO Typical Downstream Customers
- 8.4 CGT CDMO Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook